ANI Pharmaceuticals, Inc.

Q3 2025 13F Holders

Symbol
ANIP
CUSIP
00182C103
Type
Equity
Class
COM
Num filings
11
Total reported value, excl. options
$11.2 M
Manager Report Date Value ($000) Shares Option Type